Clinical Trials Sponsored by Lpath, Inc

Total 35907 results

Shantha Biotechnics Limited
PATH

Withdrawn

Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants

Rotavirus Infections

India
PATH
Bio Farma, Indonesia

Not yet recruiting

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

Poliomyelitis

Bangladesh
University of Oxford
PATH

Not yet recruiting

Southeast Asia Dose Optimization of Tafenoquine (SEADOT)

Plasmodium Vivax Malaria

Cambodia, Lao People's Democratic Republic, Thailand, Vietnam
University of Oxford
PATH

Completed

Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative (Biosensors)

Validation | Genotyping | Biosensors

Thailand
PATH
University of KwaZulu

Completed

Study to Determine Impact of Feeding Buddies on Adherence to WHO PMTCT Guidelines in South Africa

HIV | PMTCT

South Africa
Inventprise Inc.
PATH; Canadian Center for Vaccinology; Vaccine Evaluation Center, Canada

Active, not recruiting

Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine

Pneumococcal Vaccines

Canada
Inventprise Inc.
PATH; Canadian Center for Vaccinology; Vaccine Evaluation Center, Canada

Completed

Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine (IVT PCV-25)

Pneumococcal Vaccines

Canada
University of Maryland, Baltimore
PATH

Terminated

Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb

Shigella

United States
PATH
Fred Hutchinson Cancer Center

Completed

Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US

G6PD Deficiency

United States
University of Maryland, Baltimore
PATH

Completed

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP

Shigella

United States
University of Maryland, Baltimore
PATH

Terminated

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

Shigella

United States
PATH
The Emmes Company, LLC

Completed

Safety and Immunogenicity Study of Trivalent P2-VP8 Subunit Rotavirus Vaccine in Adults, Toddlers and Infants

Healthy

South Africa
PATH
Syneos Health; Research Institute for Tropical Medicine; DF/Net Research, Inc.

Completed

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

Encephalitis, Japanese | Measles | Rubella | Mumps

Philippines
PATH
Quintiles, Inc.; Mahidol University; Research Institute for Tropical Medicine...

Completed

Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine

Encephalitis, Japanese B

Philippines
PATH
Bill and Melinda Gates Foundation

Completed

Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination

Virus Diseases | Hepatitis B
PATH
University of Maryland, Baltimore; Pharmaron

Completed

Cholera Anti-Secretory Treatment Trial (CAST)

Cholera

United States
PATH
University of Oxford; Mahidol University

Completed

Comparing G6PD Tests Using Capillary Blood Versus Venous Blood

Glucose-6 Phosphate Dehydrogenase Deficiency

Thailand
PATH
Eijkman Institute for Molecular Biology

Completed

Evaluation of Different G6PD Testing Platforms

Glucose-6-Phosphate Dehydrogenase Deficiency

Indonesia
PATH
Bill and Melinda Gates Foundation

Withdrawn

Efficacy of iOWH032 in Dehydrating Cholera (POC)

Secretory Diarrhea

Bangladesh
PATH
CONRAD; Profamilia, Santo Domingo, DR

Completed

Comparative Safety Study of Two Vaginal Applicators With Tenofovir

Microbicide Applicator

Dominican Republic
Public Health Research Institute, India
PATH

Withdrawn

Human Papillomavirus Screening and Vaccine Readiness Program

Human Papilloma Virus-Related Carcinoma

India
PATH
Ashonplafa; Ministry of Health, Honduras

Completed

Honduras Liger Thermocoagulator Study

Cervix Cancer | Cervix Lesion

United States
Swiss Federal Institute of Technology
PATH

Completed

The Effect of Zinc on Iron Bioavailability From Fortified Extruded Rice Fortified With Ferric Pyrophosphate (Rice_FeZn)

Iron Deficiency

Switzerland
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
PATH
Bill and Melinda Gates Foundation; UNITAID

Recruiting

TIMCIs: A Hybrid Type 2 Study of Next-generation Pulse Oximeters

Focus of Study: Accurate Clinical Measurement and Diagnosis

Kenya
Serum Institute of India Pvt. Ltd.
PATH

Completed

Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds

Meningitis, Meningococcal

Mali
GlaxoSmithKline
The PATH Malaria Vaccine Initiative (MVI)

Completed

Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants

Malaria

Malawi
GlaxoSmithKline
The PATH Malaria Vaccine Initiative (MVI)

Recruiting

Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa

Malaria | Malaria Vaccines

Burkina Faso, Ghana, Kenya, Malawi, Senegal, Tanzania
GlaxoSmithKline
The PATH Malaria Vaccine Initiative (MVI)

Completed

Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa

Malaria

Ghana, Kenya, Mozambique, Tanzania, Burkina Faso, Gabon, Malawi
Serum Institute of India Pvt. Ltd.
PATH

Completed

Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children

Immune Response to MMR Vaccine

India
PATH
Mahidol Oxford Tropical Medicine Research Unit

Terminated

Assessing a Risk Model for G6PD Deficiency

Malaria, Vivax | G6PD Deficiency

Thailand
Serum Institute of India Pvt. Ltd.
PATH

Completed

Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

Meningococcal Meningitis

Gambia, Mali
GlaxoSmithKline
The PATH Malaria Vaccine Initiative (MVI)

Completed

Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults

Malaria

United States
GlaxoSmithKline
The PATH Malaria Vaccine Initiative (MVI)

Completed

Epidemiology Study of Malaria Transmission Intensity in Africa

Malaria | Malaria Vaccines

Ghana, Tanzania, Gabon, Kenya, Burkina Faso, Malawi
PATH
Institute of Experimental Medicine, Russia; Microgen

Completed

Reactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza Vaccine

Influenza

Russian Federation
Serum Institute of India Pvt. Ltd.
PATH

Completed

Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization

Rotavirus Gastroenteritis

India
Serum Institute of India Pvt. Ltd.
PATH

Terminated

Study Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Infants

Immune Response to DTP-HB-Hib Vaccine

India
Serum Institute of India Pvt. Ltd.
PATH

Completed

A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants

Rotavirus Gastroenteritis

India
GlaxoSmithKline
The PATH Malaria Vaccine Initiative (MVI)

Completed

Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in Children

Malaria

Nigeria
PATH
University of Virginia; Universidade Federal do Ceara; Washington University... and other collaborators

Completed

Evaluation of a Diagnostic Enteric Card for Management of Diarrhea

Diarrhea

Brazil
PATH Vaccine Solutions
Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal...

Completed

Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine

Influenza

Bangladesh
PATH
Tulane University; Sustainable Health Systems Sierra Leone

Not yet recruiting

A Short Period of Proactive Community Case Management (ProCCM) to Improve Early Care-seeking for Fever in Sierra Leone

Health Services Research
PATH
Ministry of Health, Zambia; AKROS Global Health

Completed

Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration (CORE Zambia)

Malaria

Zambia
PATH
International Centre for Diarrhoeal Disease Research, Bangladesh

Completed

Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose

Encephalitis, Japanese
PATH
International Centre for Diarrhoeal Disease Research, Bangladesh

Completed

Shigella WRSS1 Vaccine Trial in Bangladesh

Diarrhea

Bangladesh
PATH
National Institute of Hygiene and Epidemiology, Vietnam

Completed

Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil

Dose Schedule Study

Vietnam
PATH
Seattle Children's Hospital; Komfo Anokye Teaching Hospital

Completed

Nifty Feeding Cup Versus Generic Medicine Cup Preterm Infants Who Have Difficulty Breastfeeding

Feeding; Difficult, Newborn | Infant,Premature

Ghana
PATH
International Centre for Diarrhoeal Disease Research, Bangladesh

Completed

Safety Study of Live Attenuated Oral Shigella (WRSS1) Vaccine in Bangladeshi Adults and Children

Diarrhea

Bangladesh
PATH
World Health Organization; University of Cape Town

Completed

Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe

Tuberculosis

South Africa
International Centre for Diarrhoeal Disease Research...
PATH

Completed

Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab

Rotavirus Gastroenteritis

Bangladesh

Clinical Trials Sponsored by Lpath, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations